ClinicalTrials.gov
ClinicalTrials.gov Menu

NORDIC: Nitric Oxide-Derived Oxidants and Regional Endothelial and Diastolic Dysfunction in Dilated Cardiomyopathy (NORDIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00293137
Recruitment Status : Terminated (safety concerns regarding use of rosiglitazone)
First Posted : February 17, 2006
Last Update Posted : September 19, 2008
Sponsor:
Information provided by:
The Cleveland Clinic

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : August 2007